| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |